Cite
MLA Citation
Ursula A. Matulonis et al.. “Intermediate clinical endpoints: A bridge between progression‐free survival and overall survival in ovarian cancer trials.” Cancer, vol. 121, no. 11, 2015, pp. 1737–1746. http://access.bl.uk/ark:/81055/vdc_100025896579.0x000035